| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | — |
| R&D Expense | $26.1M | -68.8% |
| SG&A Expense | $52.2M | -64.5% |
| Pre-tax Income | -$205.4M | +61.6% |
| Income Tax | $850K | -57.5% |
| Net Income | -$206.3M | +61.5% |
| EPS (Basic) | -$13.65 | -1076.7% |
| EPS (Diluted) | -$13.65 | -1076.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $211.1M | -58.1% |
| Short-term Investments | $53.8M | +110.1% |
| Total Assets | $913.1M | +0.8% |
| Total Liabilities | $971.2M | +24.0% |
| Stockholders' Equity | -$58.2M | -147.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$380.0M | -137.9% |
| Capital Expenditures | $3.4M | +643.0% |
| Investing Cash Flow | -$143.8M | -272.6% |
| Financing Cash Flow | $239.1M | -37.3% |
| Free Cash Flow | -$383.4M | -139.3% |